Nexpoint Asset Management’s Amryt Pharma AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-40,000
Closed -$277K – 139
2022
Q3
$277K Hold
40,000
– – 0.02% 115
2022
Q2
$280K Hold
40,000
– – 0.02% 110
2022
Q1
$331K Hold
40,000
– – 0.04% 115
2021
Q4
$432K Hold
40,000
– – 0.06% 144
2021
Q3
$484K Hold
40,000
– – 0.08% 112
2021
Q2
$485K Sell
40,000
-40,000
-50% -$496K 0.11% 97
2021
Q1
$1.11M Hold
80,000
– – 0.29% 52
2020
Q4
$1.13M Buy
+80,000
New +$1.04M 0.37% 66

Other funds holding AMYT

Nexpoint Asset Management's AMYT Position: Q4 2022 in Review

Nexpoint Asset Management sold out of Amryt Pharma (AMYT) in Q4 2022, closing a stake of 40,000 shares — an estimated $277K sold.

Nexpoint Asset Management first reported a position in AMYT in Q4 2020 and held it in 8 quarters. The position peaked at $1.13M in Q4 2020. 58 funds tracked by Wall St. Rank hold AMYT as of Q4 2022.

  • Nexpoint Asset Management reported no remaining Amryt Pharma position as of Q4 2022 after selling out during the quarter.
  • Nexpoint Asset Management sold 40,000 Amryt Pharma shares in Q4 2022, an estimated $277K.
  • Nexpoint Asset Management first reported a position in Amryt Pharma in Q4 2020 and held it in 8 quarters.
  • Nexpoint Asset Management's Amryt Pharma position peaked at $1.13M in Q4 2020.
  • 58 funds tracked by Wall St. Rank held Amryt Pharma as of Q4 2022.

Based on Nexpoint Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.